Metreleptin

Metreleptin in Anorexia Nervosa

Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy

Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy

MEASuRE: Metreleptin Effectiveness And Safety Registry

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL

Expanded Access Metreleptin Study

Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy

Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)

Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance

The Effects of Metreleptin in Congenital Leptin Deficiency

CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy

Short-term Effects of Leptin in People With Lipodystrophy

Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)

Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy

Leptin to Treat Lipodystrophy

An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy

Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects